1. Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma
   DengYong Zhang et al, 2023, Scientific Reports CrossRef
2. A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in oral cancer
   Vinay Randhawa et al, 2015, Molecular BioSystems CrossRef
3. Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma
   Yi-Ru Pan et al, 2022, Frontiers in Immunology CrossRef
4. WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
   Luke Boulter et al, 2015, Journal of Clinical Investigation CrossRef
5. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma
   Brian K. Chung et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
6. Synthesis and Biological Evaluation of an 18Fluorine-Labeled COX Inhibitor—[18F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors
   Ying-Cheng Huang et al, 2016, Molecules CrossRef
7. Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma
   GUANGHUA YANG et al, 2016, Molecular Medicine Reports CrossRef
8. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets
   Q-X Huang et al, 2016, Cancer Gene Therapy CrossRef
9. Biomarker Identification for Liver Hepatocellular Carcinoma and Cholangiocarcinoma Based on Gene Regulatory Network Analysis
   Qiuyan Huo et al, 2021, Current Bioinformatics CrossRef
10. CAP superfamily proteins in human: a new target for cancer therapy
    Shenao Zhou et al, 2024, Medical Oncology CrossRef